Dysregulation of CD4+CD25+CD127 lowFOXP3+ regulatory T cells in HIV-infected pregnant women

Blood

Volumn 117, Issue 6, 2011, Pages 1861-1868

  Kolte, Lilian ^a   Gaardbo, Julie C ^b   Karlsson, Ingrid ^c   Sørensen, Anna Louise ^a   Ryder, Lars P ^b   Skogstrand, Kristin ^c   Ladelund, Steen ^a   Nielsen, Susanne D ^b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ABORTION; ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNE RESPONSE; LYMPHOCYTE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; REGULATORY T LYMPHOCYTE; TH2 CELL;

EID: 79951484177     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-298992     Document Type: Article

References (50)

1. Aluvihare VR, Kallikourdis M, Betz AG. Tolerance, suppression and the fetal allograft. J Mol Med. 2005;83(2):88-96. (Pubitemid 40379297)
2. Nielsen HS, Steffensen R, Varming K, et al. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet. 2009;18(9):1684-1691.
3. Bubanovic IV. Induction of thymic tolerance as possibility in prevention of recurrent spontaneous abortion. Med Hypotheses. 2003;60(4):520-524. (Pubitemid 36315278)
4. Clarke AG, Kendall MD. Histological changes in the thymus during mouse pregnancy. Thymus. 1989;14(1):65-78. (Pubitemid 20073804)
5. Kendall MD, Clarke AG. The thymus in the mouse changes its activity during pregnancy: a study of the microenvironment. J Anat. 2000;197(3):393-411.
6. Zoller AL, Schnell FJ, Kersh GJ. Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunology. 2007;121(2):207-215. (Pubitemid 46663089)
7. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5(3):266-271. (Pubitemid 38332123)
8. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004;136(2):373-378. (Pubitemid 38543459)
9. Sasaki Y, Sakai M, Miyazaki S, et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10(5):347-353. (Pubitemid 38714366)
10. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112(1):38-43. (Pubitemid 38609820)
11. Zhao JX, Zeng YY, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol. 2007;75(2):71-81. (Pubitemid 47384866)
12. Clarke AG, Kendall MD. The thymus in pregnancy: the interplay of neural, endocrine and immune influences. Immunol Today. 1994;15(11):545-551. (Pubitemid 24327569)
13. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol. 1993;151(9):4562-4573. (Pubitemid 23318510)
14. Piccinni MP, Scaletti C, Vultaggio A, Maggi E, Romagnani S. Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. J Reprod Immunol. 2001;52(1):35-43. (Pubitemid 32916377)
15. Dealtry GB, O'Farrell MK, Fernandez N. The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol. 2000;123(2):107-119.
16. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):836-848. (Pubitemid 28423498)
17. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(3):458-465.
18. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS. 1998;12(2):205-210. (Pubitemid 28035162)
19. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285(16):2083-2093. (Pubitemid 32367825)
20. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396(6712):690-695. (Pubitemid 29003949)
21. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4(2):208-214. (Pubitemid 28137376)
22. Gaardbo JC, Nielsen SD, Vedel SJ, et al. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active antiretroviral therapy. Clin Exp Immunol. 2008;154(1):80-86.
23. Kinter AL, Hennessey M, Bell A, et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med. 2004;200(3):331-343. (Pubitemid 39031252)
24. Kolte L, Gaardbo JC, Skogstrand K, et al. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol. 2009;155(1):44-52.
25. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007;21(12):1525-1534. (Pubitemid 47075472)
26. Weiss L, Donkova-Petrini V, Caccavelli L, et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004;104(10):3249-3256. (Pubitemid 39507143)
27. Schulze Zur WJ, Thomssen A, Hartjen P, et al. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol. 2010 Nov 3 [Epub ahead of print].
28. Mikyas Y, Aziz N, Harawa N, et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol. 1997;33(2):157-170. (Pubitemid 27263122)
29. Ono E, Dos Santos AM, Machado DM, et al. Immunologic features of HIV-1-infected women on HAART at delivery. Cytometry B Clin Cytom. 2008;74(4):236-243. (Pubitemid 352007321)
30. Kolte L, Dreves AM, Ersboll AK, et al. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis. 2002;185(11):1578-1585. (Pubitemid 34587519)
31. Skogstrand K, Thorsen P, Norgaard-Pedersen B, et al. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem. 2005;51(10):1854-1866. (Pubitemid 41368176)
32. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958;26:24-36.
33. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Development Core Team; 2009.
34. Zenclussen AC, Gerlof K, Zenclussen ML, et al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol. 2006;36(1):82-94. (Pubitemid 43116395)
35. Guerin LR, Prins JR, Robertson SA. Regulatory T cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009;15(5):517-535.
36. Toldi G, Svec P, Vasarhelyi B, et al. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand. 2008;87(11):1229-1233.
37. Santner-Nanan B, Peek MJ, Khanam R, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183(11):7023-7030.
38. Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol. 1998;63(3):281-287. (Pubitemid 28106840)
39. Nilsson J, Boasso A, Velilla PA, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood. 2006;108(12):3808-3817. (Pubitemid 44864563)
40. Wan YY, Flavell RA. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev. 2006;212:114-130. (Pubitemid 44116704)
41. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest. 2005;115(7):1953-1962. (Pubitemid 40979735)
42. Fritzsching B, Oberle N, Pauly E, et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood. 2006;108(10):3371-3378.
43. Haas J, Fritzsching B, Trubswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol. 2007;179(2):1322-1330.
44. Piccinni MP, Maggi E, Romagnani S. Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy. Biochem Soc Trans. 2000;28(2):212-215. (Pubitemid 30103244)
45. Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol. 2001;51(1):3-7. (Pubitemid 32594861)
46. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):827-835. (Pubitemid 28423497)
47. Hocke C, Morlat P, Chene G, Dequae L, Dabis F. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection: the Groupe d'Epidemiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol. 1995;86(6):886-891.
48. Minkoff H, Hershow R, Watts DH, et al. The relationship of pregnancy to human immunodeficiency virus disease progression. Am J Obstet Gynecol. 2003;189(2):552-559.
49. Tai JH, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007;196(7):1044-1052. (Pubitemid 47580299)
50. Le M, V, Taieb A, Longuet P, et al. Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception. HIV Med. 2008;9(10):897-900.